Home / Healthcare

Healthcare

Stocks On The Run: BioLineRx Ltd. (NASDAQ/TASE: BLRX)

BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical company focused on oncology and immunology, declared recently that Genentech, a member of the Roche Group, has begind a Phase 1b/2 study for BL-8040 in combination with atezolizumab (TECENTRIQ®), Genentech’s anti-PDL1 cancer immunotherapy agent, evaluating the combination in metastatic pancreatic ductal adenocarcinoma. Up …

Read More »

Stocks In The News: Roka Bioscience, Inc. (“Roka”) (NASDAQ: ROKA)

Roka Bioscience, Inc. (“Roka”) (NASDAQ: ROKA), a molecular diagnostics company focused on providing advanced testing solutions for the detection of foodborne pathogens, declared recently that it has reached a two year nonexclusive supply agreement with PURE Bioscience (“PURE”) to market PURE’s line of antimicrobial disinfecting and sanitizing processing aids to …

Read More »

Healthcare News In Focus: Intec Pharma Ltd. (Nasdaq: NTEC, TASE: NTEC)

Intec Pharma Ltd. (Nasdaq: NTEC, TASE: NTEC), a clinical stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill™ platform technology, declares the appointment of Jeffrey A. Meckler as Chief Executive Officer, effective right away. Mr. Meckler was named Vice Chairman of the Intec Pharma Board of …

Read More »

Healthcare Updates: Nektar Therapeutics (NASDAQ: NKTR)

Nektar Therapeutics (NASDAQ: NKTR) recently declared positive preclinical results for NKTR-358, a first-in-class resolution therapeutic for autoimmune disease. The new preclinical data demonstrate that treatment with NKTR-358 induces profound regulatory T cell effects and suppresses inflammation in multiple preclinical models. The data were highlighted in an oral presentation at the …

Read More »

Healthcare News updates: Valeant Pharmaceuticals International, Inc.’s (NYSE: VRX and TSX: VRX)

Valeant Pharmaceuticals International, Inc.’s (NYSE: VRX and TSX: VRX) wholly owned partner, Bausch + Lomb, a leading global eye health company, recently declared the introduction of Bausch + Lomb AQUALOX® contact lenses, the first new innovation in the bi-weekly contact lens category in half a decade, to the Japanese market. …

Read More »

Healthcare Stocks Buzz; Titan Pharmaceuticals, Inc. (NASDAQ: TTNP)

Titan Pharmaceuticals, Inc. (NASDAQ: TTNP), a specialty pharmaceutical company developing proprietary therapeutics for the treatment of select chronic diseases utilizing its ProNeura™ long-term, continuous drug delivery technology, declared recently that it has reached a Cooperative Research and Development Agreement (CRADA) with Walter Reed Army Institute of Research (WRAIR) and Southwest …

Read More »

Stocks Buzz: Trovagene, Inc. (NASDAQ: TROV)

Trovagene, Inc. (NASDAQ: TROV), a precision medicine biotechnology company, declared recently that is has formally engaged PRA Health Sciences, a leading, global contract research organization (CRO), to conduct Trovagene’s Phase 1b/2 clinical trial of PCM-075, a polo-like kinase 1 (PLK1) inhibitor, in patients with acute myeloid leukemia (AML). Trovagene filed …

Read More »

Healthcare News Buzz: Viking Therapeutics, Inc. (“Viking”) (NASDAQ: VKTX)

Viking Therapeutics, Inc. (“Viking”) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, recently declared the appointment of Charles A. Rowland Jr. to its board of directors. With more than 30 years of biopharmaceutical industry experience, Mr. Rowland provides Viking with …

Read More »

Healthcare News Updates: IsoRay, Inc. (NYSE MKT: ISR)

IsoRay, Inc. (NYSE MKT: ISR), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications for the treatment of prostate, brain, lung, head and neck and gynecological cancers, recently declared that it has received a response from the FDA regarding the Company’s pending 510(k) application for the …

Read More »